PHI with Abduction inhibition (Developmental Dysplasia of the Hip)
How does this condition affect your private health insurance?
Abspreizhemmung, or abduction inhibition, describes a restricted outward movement of the hip, most commonly observed in infants. It is a critical clinical sign highly indicative of Developmental Dysplasia of the Hip (DDH), a condition where the hip joint is abnormally formed, potentially leading to instability, subluxation, or complete dislocation. This limitation can affect one or both hips. Early detection is paramount, as untreated DDH can result in gait abnormalities, chronic pain, leg length discrepancy, and early-onset osteoarthritis in adulthood. Routine neonatal screening includes assessing hip abduction to identify this potential issue promptly, allowing for timely intervention and improved long-term outcomes.
PKV Risk Assessment
However, some specialized PHI providers may insure you with a surcharge of up to 10%.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Present from birth, typically diagnosed within the first weeks or months of life during routine screenings.
Duration of Illness (Lifetime)
Chronic if untreated, leading to lifelong complications; potentially short-term (months to a few years) with successful early treatment.
Cost of Treatment (Initial)
Varies significantly: low for diagnostic tests and conservative bracing (e.g., Pavlik harness), moderate to high for surgical intervention, typically ranging from a few hundred to several thousand USD/EUR.
Cost of Treatment (Lifetime)
Can be minimal (initial treatment only) if detected and treated early, but potentially very high over a lifetime (tens of thousands to hundreds of thousands USD/EUR) if severe, untreated, or requiring multiple surgeries, rehabilitation, and management of secondary osteoarthritis.
Mortality Rate
Extremely low; DDH itself is not life-threatening. Risks are primarily associated with surgical complications (e.g., anesthesia, infection), which are rare.
Risk of Secondary Damages
High if untreated, leading to chronic pain, limping, leg length discrepancy, premature osteoarthritis, and potential need for total hip replacement in adulthood. Lower with early, successful treatment.
Probability of Full Recovery
High (over 90%) with early detection and appropriate conservative treatment (e.g., Pavlik harness). Decreases significantly if diagnosis is delayed or if surgical intervention is required, though good outcomes are still common.
Underlying Disease Risk
Generally low for other serious systemic diseases. However, DDH is associated with risk factors like breech presentation, oligohydramnios, and family history. It can occasionally co-occur with other congenital orthopedic issues such as clubfoot or congenital muscular torticollis.